Drawing for NORTHWAY SURGICAL CENTER

USPTO serial 79302490

NORTHWAY SURGICAL CENTER

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
LIEBL, ALEXANDRA
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NORTHWAY SURGICAL CENTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes; albuminous preparations for medical purposes, namely, albumin dietary supplements; chemical preparations for medical purposes, namely for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19ABANDONED
042Scientific and technological services, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of manufacture processes for biotechnology products; technological consultation in the field of development of manufacturing processes for biotechnology productsABANDONED
044Medical services; midwife services; alternative medicine services; in vitro fertilization services; chiropractic services; physiotherapy; occupational therapy services; human tissue bank services; hospital services; rental of medical equipment; medical advice for individuals with disabilities; medical clinic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; opticians' services; plastic surgery; services of a psychologist; convalescent home services; preparation of prescriptions by pharmacists; rehabilitation of substance abuse patients; nursing, medical; health centre services; health counselling; medical screening; health care; telemedicine servicesABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 12, 2023FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Aug 24, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 24, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 25, 2022MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Aug 24, 2022ABN4ABANDONMENT - AFTER INTER PARTES DECISION
Aug 24, 2022OP.TOPPOSITION TERMINATED NO. 999999
Aug 24, 2022OP.DOPPOSITION DISMISSED NO. 999999
Jul 11, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 23, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 22, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 6, 2021RFNTREFUSAL PROCESSED BY IB
Nov 20, 2021OP.IOPPOSITION INSTITUTED NO. 999999
Nov 8, 2021OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Nov 6, 2021OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED
Nov 5, 2021OPPFOPPOSITION PAPERS RECEIVED AT TTAB
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 22, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 21, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 20, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 20, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 20, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 20, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 16, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 13, 2021RFNTREFUSAL PROCESSED BY IB
Mar 25, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 25, 2021RFRRREFUSAL PROCESSED BY MPU
Mar 20, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 19, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 15, 2021DOCKASSIGNED TO EXAMINER
Jan 26, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 22, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 21, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance